J. Dietl Hospital, Krakow Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2013
NCT02132234
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Department of Rheumatology, J. Dietl Hospital, Krakow, Poland | Departmet of Rheumatology, J Dietl Hospital, Krakow, Poland

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Psoriatic (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Spondylitis (Phase 4)

Spondylitis, Ankylosing (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 4